Levy Lauds Biomarker-Driven Data in Lung Cancer
Season 4, Episode 39, Mar 11, 2021, 09:08 PM
Dr. Levy discusses key research efforts with targeted therapies for patients with lung cancer who harbor NTRK, KRAS, and HER2 aberrations.
Dr. Levy discusses key research efforts with targeted therapies for patients with lung cancer who harbor NTRK, KRAS, and HER2 aberrations.
You can visit our support center if you're having problems.